CONTINUOUS CHLORAMBUCIL THERAPY IN PRIMARY MACROGLOBULINEMIA OF WALDENSTROM - REPORT OF 4 CASES

被引：0
|
作者：
BAYRD, ED
机构：
来源：
PROCEEDINGS OF THE STAFF MEETINGS OF THE MAYO CLINIC | 1961年 / 36卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：135 / &
相关论文
共 50 条
  • [21] Waldenstrom macroglobulinemia: biology, genetics, and therapy
    Paludo, Jonas
    Ansell, Stephen M.
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2016, 6 : 49 - 58
  • [22] Waldenstrom's macroglobulinemia: A review of therapy
    Gertz, MA
    LEUKEMIA & LYMPHOMA, 2002, 43 (08) : 1517 - 1526
  • [23] Activity of fludarabine in previously treated Waldenstrom's macroglobulinemia: A report of 71 cases
    Leblond, V
    Ben-Othman, T
    Deconinck, E
    Taksin, AL
    Harousseau, JL
    Delgado, MA
    Delmer, A
    Maloisel, F
    Mariette, X
    Morel, P
    Clauvel, JP
    Duboisset, P
    Entezam, S
    Hermine, O
    Merlet, M
    Yakoub-Agha, I
    Guibon, O
    Caspard, H
    Fort, N
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) : 2060 - 2064
  • [24] Lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia associated with Hodgkin disease - A report of two cases
    Rosales, CM
    Lin, P
    Mansoor, A
    Bueso-Ramos, C
    Medeiros, LJ
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 116 (01) : 34 - 40
  • [25] Choice of Therapy for Patients With Waldenstrom Macroglobulinemia
    Ghobrial, Irene M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) : 291 - 293
  • [26] Bendamustine rituximab primary therapy for Waldenstrom Macroglobulinemia: an international, multicenter collaborative study
    Zanwar, Saurabh
    Abeykoon, Jithma
    Castillo, Jorge
    Durot, Eric
    Kastritis, Efstathios
    Uppal, Encarl
    Morel, Pierre
    Tawfiq, Reema
    Montes, Lydia
    Paludo, Jonas
    Saroseik, Shayna
    Kumar, Shaji
    Ogunbiyi, Olabisi
    Cornillet-Lefebvre, Pascale
    Kyle, Robert
    Delmer, Alain
    Gertz, Morie
    Dimopoulos, Meletios A.
    Ansell, Stephen
    Treon, Steven
    D'Sa, Shirley
    Kapoor, Prashant
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S127 - S128
  • [27] Prospective Clinical Trial of Ixazomib, Dexamethasone, and Rituximab as Primary Therapy in Waldenstrom Macroglobulinemia
    Castillo, Jorge J.
    Meid, Kirsten
    Gustine, Joshua N.
    Dubeau, Toni
    Severns, Patricia
    Hunter, Zachary R.
    Yang, Guang
    Xu, Lian
    Treon, Steven P.
    CLINICAL CANCER RESEARCH, 2018, 24 (14) : 3247 - 3252
  • [28] Primary systemic amyloidosis in patients with Waldenstrom macroglobulinemia
    Zanwar, Saurabh
    Abeykoon, Jithma P.
    Ansell, Stephen M.
    Gertz, Morie A.
    Dispenzieri, Angela
    Muchtar, Eli
    Sidana, Surbhi
    Tandon, Nidhi
    Rajkumar, S. Vincent
    Dingli, David
    Go, Ronald
    Lacy, Martha Q.
    Kourelis, Taxiarchis
    Witzig, Thomas E.
    Inwards, David
    Buadi, Francis
    Gonsalves, Wilson
    Habermann, Thomas
    Johnston, Patrick
    Nowakowski, Grzegorz
    Kyle, Robert A.
    Kumar, Shaji
    Kapoor, Prashant
    LEUKEMIA, 2019, 33 (03) : 790 - 794
  • [29] PRIMARY FSGS IN A PATIENT WITH WALDENSTROM'S MACROGLOBULINEMIA
    Vandani, Golnaz
    Albasha, Waseem
    Yousman, Wina
    Bracamonte, Erika
    Thajudeen, Bijin
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 648 - 648
  • [30] IMMUNOLOGICAL AND CLINICAL VARIANTS OF PRIMARY MACROGLOBULINEMIA (WALDENSTROM)
    RITZMANN, SE
    LEVIN, WC
    BLOOD, 1962, 20 (06) : 791 - &
12345